Literature DB >> 4998346

Preparation and standardization of an Australia antigen antibody of equine origin.

V J Cabasso, R Nieman, D D Schroeder, K A Hok, R E Louie, M M Mozen.   

Abstract

A horse has been immunized with Australia antigen (Au/SH) purified 20-fold by a procedure employing gel filtration of Cohn fraction IV derived from an Au/SH-positive human plasma pool. Hyperimmunization was initiated by the intramuscular injection of 20 ml of a mixture of equal parts of purified Au/SH and complete Freund's adjuvant. The 20-ml volume was divided into four 5-ml doses, two of which were administered on each side of the horse's neck. Booster doses of antigen alone were given as follows: 10 ml intravenously 30 days later and 5 ml intramuscularly on each of days 77 and 205. Au/SH antibody formed readily, beginning on day 17, and was demonstrated by the agar gel double-diffusion technique and the complement fixation test during the subsequent 6 months. Antihuman plasma protein antibodies were effectively removed from the horse serum by one absorption with 1 to 3 volumes of normal human plasma. Abrupt rises in anticomplementary activity observed shortly after the third and fourth antigen injections, when the horse had developed elevated and steady levels of Au/SH antibody, could possibly be due to formation of antigen-antibody complexes. After optimal conditions were determined, an Au/SH antibody reagent pool which met official requirements was prepared. It was found equally suitable for the agar gel double-diffusion, complement fixation, and counterimmunoelectrophoresis test procedures.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4998346      PMCID: PMC377335          DOI: 10.1128/am.21.6.1017-1023.1971

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  14 in total

1.  A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis.

Authors:  B S Blumberg; B J Gerstley; D A Hungerford; W T London; A I Sutnick
Journal:  Ann Intern Med       Date:  1967-05       Impact factor: 25.391

2.  Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation.

Authors:  N R Shulman; L F Barker
Journal:  Science       Date:  1969-07-18       Impact factor: 47.728

3.  The production of antibodies to Australia antigen in mouse ascites fluid.

Authors:  I Millman; J F Ziegenfuss; V Raunio; W T London; A I Sutnick; B S Blumberg
Journal:  Proc Soc Exp Biol Med       Date:  1970-04

4.  An antigen detected in the blood during the incubation period of serum hepatitis.

Authors:  A M Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1968-07       Impact factor: 11.205

5.  Preparation and characterization of complement-fixing hepatitis-associated antigen and antiserum.

Authors:  R H Purcell; J L Gerin; P V Holland; W L Cline; R M Chanock
Journal:  J Infect Dis       Date:  1970-02       Impact factor: 5.226

6.  Australia antigen: distribution during Cohn ethanol fractionation of human plasma.

Authors:  D D Schroeder; M M Mozen
Journal:  Science       Date:  1970-06-19       Impact factor: 47.728

7.  Hepatitis and leukemia: their relation to Australia antigen.

Authors:  B S Blumberg; A I Sutnick; W T London
Journal:  Bull N Y Acad Med       Date:  1968-12

8.  Rapid detection of Australia antigen by counterimmunoelectrophoresis.

Authors:  D J Gocke; C Howe
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

9.  Australia antigen-antibody complexes.

Authors:  I Millman; W T London; A I Sutnick; B S Blumberg
Journal:  Nature       Date:  1970-04-04       Impact factor: 49.962

10.  Production of antibody against "Australia antigen" in rabbits.

Authors:  L Melartin; B S Blumberg
Journal:  Nature       Date:  1966-06-25       Impact factor: 49.962

View more
  5 in total

1.  Induction of hepatitis B antibody in experimental animals by immunization with A-2 plaque virus.

Authors:  E D Shaw; A P McKee; M Rancourt; L Hollenbeck
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

2.  Concentration and purification of hepatitis B antigen with polyethylene glycol and polyelectrolyte 60, a cross-linked copolymer of isobutylene maleic anhydride.

Authors:  E De Rizzo; R Pandey; C Wallis; J L Melnick
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

3.  Liver function and histology in asymptomatic Chinese military personnel with hepatitis B antigenemia.

Authors:  K E Anderson; S C Sun; H S Berg; N K Chang
Journal:  Am J Dig Dis       Date:  1974-08

4.  A simple procedure for purification of hepatitis B-antigen.

Authors:  A Cruceanu; R Müller; H Deicher
Journal:  Med Microbiol Immunol       Date:  1973-09-26       Impact factor: 3.402

5.  Production of potent anti-Australia antigen sera of high specificity and sensitivity in goats.

Authors:  G R Dreesman; F B Hollinger; R M McCombs; J L Melnick
Journal:  Infect Immun       Date:  1972-02       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.